Invivyd (IVVD) Enterprise Value (2020 - 2025)
Invivyd (IVVD) reported Enterprise Value of -$226.7 million for Q4 2025, down 226.88% on a YoY basis from $178.7 million in Q4 2024, and down 166.8% quarter-over-quarter from -$85.0 million in Q3 2025.
Invivyd (IVVD) Enterprise Value (2020 - 2025) Analysis & Trends
Invivyd has reported Enterprise Value for 6 years, with the latest figure at -$226.7 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 226.88% year-over-year to -$226.7 million; the trailing twelve-month figure through Dec 2025 stood at -$226.7 million (down 226.88% YoY), and the FY2025 full-year result was -$226.7 million, down 226.88% from the prior year.
- Enterprise Value for Q4 2025 stood at -$226.7 million, down from -$85.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$34.9 million in Q2 2025, with the low at -$542.2 million in Q4 2021.
- Historically, Enterprise Value has averaged -$227.9 million across 5 years, with a median of -$181.8 million in 2023.
- Annual changes were most pronounced in 2021 — Enterprise Value plunged 371.55% — and 2022, when it jumped 83.02%.
- Invivyd's Enterprise Value stood at -$542.2 million in 2021, then jumped by 83.02% to -$92.1 million in 2022, then plunged by 117.91% to -$200.6 million in 2023, then soared by 65.44% to -$69.3 million in 2024, then sank by 226.88% to -$226.7 million in 2025.
- The last three Enterprise Value figures came in at -$226.7 million (Q4 2025), -$85.0 million (Q3 2025), and -$34.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | -226.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -226.69 Mn |
| Sep 30, 2025 | -84.97 Mn |
| Jun 30, 2025 | -34.91 Mn |
| Mar 31, 2025 | -48.08 Mn |
| Dec 31, 2024 | -69.35 Mn |
| Sep 30, 2024 | -106.87 Mn |
| Jun 30, 2024 | -147.88 Mn |
| Mar 31, 2024 | -189.39 Mn |
| Dec 31, 2023 | -200.64 Mn |
| Sep 30, 2023 | -181.82 Mn |
| Jun 30, 2023 | -121.95 Mn |
| Mar 31, 2023 | -126.47 Mn |
| Dec 31, 2022 | -92.08 Mn |
| Sep 30, 2022 | -278.15 Mn |
| Jun 30, 2022 | -474.89 Mn |
| Mar 31, 2022 | -532.22 Mn |
| Dec 31, 2021 | -542.22 Mn |
| Sep 30, 2021 | -478.27 Mn |
| Jun 30, 2021 | -392.51 Mn |
| Dec 31, 2020 | -114.99 Mn |